Treatment of recalcitrant atopic dermatitis with omalizumab.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 16384758.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Atopic dermatitis is a common diagnosis that presents a therapeutic challenge. Although multiple therapeutic modalities exist, there is no single monotherapy that has proven exceptional in ameliorating the symptoms of this disease. Current topical and systemic therapeutic options offer benefit but carry varying degrees of adverse effects that often limit their application. We present 3 patients with severe, recalcitrant atopic dermatitis successfully treated with omalizumab.
Medical subject headings
- Antibodies, Monoclonal
- Dermatitis, Atopic